Asia Sentinel

Asia Sentinel

Promising New Drug for Children Living with HIV

Asia Sentinel's avatar
Asia Sentinel
Dec 10, 2019
∙ Paid
Share

An easy-to-consume, heat-stable, fixed-dose combination of four antiretrovirals (ARVs) developed for HIV-infected infants and young children weighing 3 to 25 kg is currently under review by the US Food and Drug Administration (FDA).

If approved by the FDA, this all-in-one regimen, consisting of the four antiretroviral medicines lopinavir, ritonavir, abac…

Keep reading with a 7-day free trial

Subscribe to Asia Sentinel to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Asia Sentinel
Publisher Privacy
Substack
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture